{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T14:03:01Z","timestamp":1788012181040,"version":"build-2784847793"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T00:00:00Z","timestamp":1627689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T00:00:00Z","timestamp":1627689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81100947"],"award-info":[{"award-number":["81100947"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12031-021-01869-9","type":"journal-article","created":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T04:14:59Z","timestamp":1627704899000},"page":"2646-2658","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Mutant Huntingtin Impairs Pancreatic \u03b2-cells by Recruiting IRS-2 and Disturbing the PI3K\/AKT\/FoxO1 Signaling Pathway in Huntington\u2019s Disease"],"prefix":"10.1007","volume":"71","author":[{"given":"Li","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2157-2134","authenticated-orcid":false,"given":"Cuifang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,31]]},"reference":[{"issue":"3","key":"1869_CR1","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1006\/nbdi.2002.0562","volume":"11","author":"OA Andreassen","year":"2002","unstructured":"Andreassen OA, Dedeoglu A, Stanojevic V, Hughes DB, Browne SE, Leech CA, Ferrante RJ, Habener JF, Beal MF, Thomas MK (2002) Huntington\u2019s disease of the endocrine pancreas: Insulin deficiency and diabetes mellitus due to impaired insulin gene expression. Neurobiol Dis 11(3):410\u2013424. https:\/\/doi.org\/10.1006\/nbdi.2002.0562","journal-title":"Neurobiol Dis"},{"key":"1869_CR2","doi-asserted-by":"publisher","unstructured":"Bendlin BB (2019) Antidiabetic therapies and Alzheimer disease. Dialogues Clin Neurosci 21(1):83\u201391. https:\/\/doi.org\/10.31887\/DCNS.2019.21.1\/bblendin","DOI":"10.31887\/DCNS.2019.21.1\/bblendin"},{"issue":"11","key":"1869_CR3","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1172\/JCI13785","volume":"108","author":"E Bernal-Mizrachi","year":"2001","unstructured":"Bernal-Mizrachi E, Wen W, Stahlhut S, Welling CM, Permutt MA (2001) Islet beta cell expression of constitutively active Akt1\/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J Clin Invest 108(11):1631\u20131638. https:\/\/doi.org\/10.1172\/JCI13785","journal-title":"J Clin Invest"},{"issue":"3","key":"1869_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118765","volume":"10","author":"MT Besson","year":"2015","unstructured":"Besson MT, Alegr\u00eda K, Garrido-Gerter P, Barros LF, Li\u00e9vens JC (2015) Enhanced neuronal glucose transporter expression reveals metabolic choice in a HD Drosophila model. PLoS ONE 10(3):e0118765. https:\/\/doi.org\/10.1371\/journal.pone.0118765","journal-title":"PLoS ONE"},{"issue":"5","key":"1869_CR5","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/hmg\/ddi053","volume":"14","author":"M Bj\u00f6rkqvist","year":"2005","unstructured":"Bj\u00f6rkqvist M, Fex M, Renstr\u00f6m E, Wierup N, Peters\u00b4en A, Gil J, Bacos K, Popovic N, Li JY, Sundler F, Brundin P, Mulder H, (2005) The R6\/2 transgenic mouse model of Huntington\u2019s disease develops diabetes due to deficient beta-cell mass and exocytosis. Hum Mol Genet 14(5):565\u2013574. https:\/\/doi.org\/10.1093\/hmg\/ddi053","journal-title":"Hum Mol Genet"},{"issue":"3","key":"1869_CR6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3233\/JHD-190366","volume":"8","author":"IC Br\u00e1s","year":"2019","unstructured":"Br\u00e1s IC, K\u00f6nig A, Outeiro TF (2019) Glycation in Huntington\u2019s Disease: A Possible Modifier and Target for Intervention. J Huntingtons Dis 8(3):245\u2013256. https:\/\/doi.org\/10.3233\/JHD-190366","journal-title":"J Huntingtons Dis"},{"key":"1869_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-3-319-60189-2_6","volume":"18","author":"MR Bryan","year":"2017","unstructured":"Bryan MR, Bowman AB (2017) Manganese and the Insulin-IGF Signaling Network in Huntington\u2019s Disease and Other Neurodegenerative Disorders. Adv Neurobiol 18:113\u2013142. https:\/\/doi.org\/10.1007\/978-3-319-60189-2_6","journal-title":"Adv Neurobiol"},{"issue":"5","key":"1869_CR8","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/hmg\/ddl481","volume":"16","author":"MC Chiang","year":"2007","unstructured":"Chiang MC, Chen HM, Lee YH, Chang HH, Wu YC, Soong BW, Chen CM, Wu YR, Liu CS, Niu DM, Wu JY, Chen YT, Chern Y (2007) Dysregulation of C\/EBPalpha by mutant Huntingtin causes the urea cycle deficiency in Huntington\u2019s disease. Hum Mol Genet 16(5):483\u2013498. https:\/\/doi.org\/10.1093\/hmg\/ddl481","journal-title":"Hum Mol Genet"},{"issue":"6","key":"1869_CR9","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2217\/fnl.12.72","volume":"7","author":"ZZ Chong","year":"2012","unstructured":"Chong ZZ, Shang YC, Wang S, Maiese K (2012) A Critical Kinase Cascade in Neurological Disorders: PI 3-K, Akt, and mTOR. Future Neurol 7(6):733\u2013748. https:\/\/doi.org\/10.2217\/fnl.12.72","journal-title":"Future Neurol"},{"issue":"3","key":"1869_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S1474-4422(04)00681-7","volume":"3","author":"S Craft","year":"2004","unstructured":"Craft S, Watson GS (2004) Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 3(3):169\u2013178. https:\/\/doi.org\/10.1016\/S1474-4422(04)00681-7","journal-title":"Lancet Neurol"},{"issue":"6","key":"1869_CR11","doi-asserted-by":"publisher","first-page":"705","DOI":"10.4161\/cc.6.6.4035","volume":"6","author":"RK Dearth","year":"2007","unstructured":"Dearth RK, Cui X, Kim HJ, Hadsell DL, Lee AV (2007) Oncogenic transformation by the signaling adaptor proteins insulin receptor substrate (IRS)-1 and IRS-2. Cell Cycle 6(6):705\u2013713. https:\/\/doi.org\/10.4161\/cc.6.6.4035","journal-title":"Cell Cycle"},{"key":"1869_CR12","doi-asserted-by":"publisher","first-page":"3695689","DOI":"10.1155\/2020\/3695689","volume":"2020","author":"LJ Du","year":"2020","unstructured":"Du LJ, Pang B, Tan YM, Yang YN, Zhang MZ, Pang Q, Sun M, Ni Q (2020) Banxia Xiexin Decoction Ameliorates t-BHP-Induced Apoptosis in Pancreatic Beta Cells by Activating the PI3K\/AKT\/FOXO1 Signaling Pathway. J Diabetes Res 2020:3695689. https:\/\/doi.org\/10.1155\/2020\/3695689","journal-title":"J Diabetes Res"},{"key":"1869_CR13","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1399-0004.1985.tb00185.x","volume":"27","author":"LA Farrer","year":"1985","unstructured":"Farrer LA (1985) Diabetes mellitus in Huntington disease. Clin Genet 27:62\u201367. https:\/\/doi.org\/10.1111\/j.1399-0004.1985.tb00185.x","journal-title":"Clin Genet"},{"issue":"1","key":"1869_CR14","doi-asserted-by":"publisher","first-page":"E187","DOI":"10.1152\/ajpendo.00283.2006","volume":"292","author":"E Fern\u00e1ndez","year":"2007","unstructured":"Fern\u00e1ndez E, Mart\u00edn MA, Fajardo S, Escriv\u00e1 F, Alvarez C (2007) Increased IRS-2 content and activation of IGF-I pathway contribute to enhance beta-cell mass in fetuses from undernourished pregnant rats. Am J Physiol Endocrinol Metab 292(1):E187\u2013E195. https:\/\/doi.org\/10.1152\/ajpendo.00283.2006","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"1869_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2174\/157339913804143225","volume":"9","author":"Z Fu","year":"2013","unstructured":"Fu Z, Gilbert ER, Liu D (2013) Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes. Curr Diabetes Rev 9(1):25\u201353","journal-title":"Curr Diabetes Rev"},{"key":"1869_CR16","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1046\/j.1471-4159.1994.63041392.x","volume":"63","author":"WC Gamberino","year":"1994","unstructured":"Gamberino WC, Brennan WA Jr (1994) Glucose transporter isoform expression in Huntington\u2019s disease brain. J Neurochem 63:1392\u20131397. https:\/\/doi.org\/10.1046\/j.1471-4159.1994.63041392.x","journal-title":"J Neurochem"},{"key":"1869_CR17","doi-asserted-by":"publisher","first-page":"4650906","DOI":"10.1155\/2019\/4650906","volume":"2019","author":"JR Gao","year":"2019","unstructured":"Gao JR, Qin XJ, Fang ZH, Li-Shan HLP, Hui-Jiang GMF, Jiang NN (2019) To Explore the Pathogenesis of Vascular Lesion of Type 2 Diabetes Mellitus Based on the PI3K\/Akt Signaling Pathway. J Diabetes Res 2019:4650906. https:\/\/doi.org\/10.1155\/2019\/4650906","journal-title":"J Diabetes Res"},{"issue":"5","key":"1869_CR18","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1463-1326.2011.01536.x","volume":"14","author":"AJ Garber","year":"2012","unstructured":"Garber AJ (2012) Obesity and type 2 diabetes: which patients are at risk? Diabetes Obes Metab 14(5):399\u2013408. https:\/\/doi.org\/10.1111\/j.1463-1326.2011.01536.x","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"1869_CR19","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1111\/j.1460-9568.2008.06310.x","volume":"27","author":"JM Gil","year":"2008","unstructured":"Gil JM, Rego AC (2008) Mechanisms of neurodegeneration in Huntington\u2019s disease. Eur J Neurosci 27(11):2803\u20132820. https:\/\/doi.org\/10.1111\/j.1460-9568.2008.06310.x","journal-title":"Eur J Neurosci"},{"issue":"11","key":"1869_CR20","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.7150\/ijbs.27173","volume":"14","author":"X Huang","year":"2018","unstructured":"Huang X, Liu G, Guo J, Su Z (2018) The PI3K\/AKT pathway in obesity and type 2 diabetes. Int J Biol Sci 14(11):1483\u20131496. https:\/\/doi.org\/10.7150\/ijbs.27173","journal-title":"Int J Biol Sci"},{"issue":"2","key":"1869_CR21","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s00221-005-2357-z","volume":"166","author":"MJ Hunt","year":"2005","unstructured":"Hunt MJ, Morton AJ (2005) Atypical diabetes associated with inclusion formation in the R6\/2 mouse model of Huntington\u2019s disease is not improved by treatment with hypoglycaemic agents. Exp Brain Res 166(2):220\u2013229. https:\/\/doi.org\/10.1007\/s00221-005-2357-z","journal-title":"Exp Brain Res"},{"key":"1869_CR22","doi-asserted-by":"publisher","first-page":"649","DOI":"10.2337\/diabetes.48.3.649","volume":"48","author":"MS Hurlbert","year":"1999","unstructured":"Hurlbert MS, ZhouW WC, Kaddis FG, Hutton JC, Freed CR (1999) Mice transgenic for an expanded CAG repeat in the Huntington\u2019s disease gene develop diabetes. Diabetes 48:649\u2013651. https:\/\/doi.org\/10.2337\/diabetes.48.3.649","journal-title":"Diabetes"},{"issue":"4","key":"1869_CR23","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3233\/JAD-131847","volume":"40","author":"Y Hu","year":"2014","unstructured":"Hu Y, Liang J, Yu S (2014) High prevalence of diabetes mellitus in a five-generation Chinese family with Huntington\u2019s disease. J Alzheimers Dis 40(4):863\u2013868. https:\/\/doi.org\/10.3233\/JAD-131847","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"1869_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1365-2826.2007.01629.x","volume":"20","author":"K Josefsen","year":"2008","unstructured":"Josefsen K, Nielsen MD, J\u00f8rgensen KH, Bock T, N\u00f8rrem\u00f8lle A, S\u00f8rensen SA, Naver B, Hasholt L (2008) Impaired glucose tolerance in the R6\/1 transgenic mouse model of Huntington\u2019s disease. J Neuroendocrinol 20(2):165\u2013172. https:\/\/doi.org\/10.1111\/j.1365-2826.2007.01629.x","journal-title":"J Neuroendocrinol"},{"issue":"2","key":"1869_CR25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1507\/endocrj.k07e-041","volume":"55","author":"H Kaneto","year":"2008","unstructured":"Kaneto H, Miyatsuka T, Kawamori D, Yamamoto K, Kato K, Shiraiwa T, Katakami N, Yamasaki Y, Matsuhisa M, Matsuoka TA (2008) PDX-1 and MafA play a crucial role in pancreatic beta-cell differentiation and maintenance of mature beta-cell function. Endocr J 55(2):235\u2013252. https:\/\/doi.org\/10.1507\/endocrj.k07e-041","journal-title":"Endocr J"},{"issue":"2","key":"1869_CR26","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1074\/jbc.M508510200","volume":"281","author":"D Kawamori","year":"2006","unstructured":"Kawamori D, Kaneto H, Nakatani Y, Matsuoka TA, Matsuhisa M, Hori M, Yamasaki Y (2006) The forkhead transcription factor Foxo1 bridges the JNK pathway and the transcription factor PDX-1 through its intracellular translocation. J Biol Chem 281(2):1091\u20131098. https:\/\/doi.org\/10.1074\/jbc.M508510200","journal-title":"J Biol Chem"},{"issue":"19","key":"1869_CR27","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1093\/hmg\/11.19.2279","volume":"11","author":"H Kita","year":"2002","unstructured":"Kita H, Carmichael J, Swartz J, Muro S, Wyttenbach A, Matsubara K, Rubinsztein DC, Kato K (2002) Modulation of polyglutamine-induced cell death by genes identified by expression profiling. Hum Mol Genet 11(19):2279\u20132287. https:\/\/doi.org\/10.1093\/hmg\/11.19.2279","journal-title":"Hum Mol Genet"},{"issue":"4","key":"1869_CR28","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1001\/archneur.65.4.476","volume":"65","author":"NM Lali\u0107","year":"2008","unstructured":"Lali\u0107 NM, Mari\u0107 J, Svetel M, Joti\u0107 A, Stefanova E, Lali\u0107 K, Dragasevi\u0107 N, Milici\u0107 T, Luki\u0107 L, Kosti\u0107 VS (2008) Glucose homeostasis in Huntington disease: abnormalities in insulin sensitivity and early-phase insulin secretion. Arch Neurol 65(4):476\u2013480. https:\/\/doi.org\/10.1001\/archneur.65.4.476","journal-title":"Arch Neurol"},{"key":"1869_CR29","doi-asserted-by":"publisher","unstructured":"Liao Z, Zhang J, Liu B, Yan T, Xu F, Xiao F, Wu B, Bi K, Jia Y (2019) Polysaccharide from Okra (Abelmoschus esculentus (L.) Moench) Improves Antioxidant Capacity via PI3K\/AKT Pathways and Nrf2 Translocation in a Type 2 Diabetes Model. Molecules 24(10):1906. https:\/\/doi.org\/10.3390\/molecules24101906","DOI":"10.3390\/molecules24101906"},{"issue":"23","key":"1869_CR30","doi-asserted-by":"publisher","first-page":"15884","DOI":"10.1074\/jbc.M600356200.Erratum.In:JBiolChem.2006Aug11;281(32):23296","volume":"281","author":"MK Lingohr","year":"2006","unstructured":"Lingohr MK, Briaud I, Dickson LM, McCuaig JF, Al\u00e1rcon C, Wicksteed BL, Rhodes CJ (2006) Specific regulation of IRS-2 expression by glucose in rat primary pancreatic islet beta-cells. J Biol Chem 281(23):15884\u201315892. https:\/\/doi.org\/10.1074\/jbc.M600356200.Erratum.In:JBiolChem.2006Aug11;281(32):23296","journal-title":"J Biol Chem"},{"issue":"6","key":"1869_CR31","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.2337\/db05-0678","volume":"55","author":"SC Martinez","year":"2006","unstructured":"Martinez SC, Cras-M\u00e9neur C, Bernal-Mizrachi E, Permutt MA (2006) Glucose regulates Foxo1 through insulin receptor signaling in the pancreatic islet beta-cell. Diabetes 55(6):1581\u20131591. https:\/\/doi.org\/10.2337\/db05-0678","journal-title":"Diabetes"},{"issue":"4","key":"1869_CR32","doi-asserted-by":"publisher","first-page":"846","DOI":"10.2337\/db07-0595","volume":"57","author":"SC Martinez","year":"2008","unstructured":"Martinez SC, Tanabe K, Cras-M\u00e9neur C, Abumrad NA, Bernal-Mizrachi E, Permutt MA (2008) Inhibition of Foxo1 protects pancreatic islet beta-cells against fatty acid and endoplasmic reticulum stress-induced apoptosis. Diabetes 57(4):846\u2013859. https:\/\/doi.org\/10.2337\/db07-0595","journal-title":"Diabetes"},{"key":"1869_CR33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s40478-014-0178-7","volume":"2","author":"H McClory","year":"2014","unstructured":"McClory H, Williams D, Sapp E, Gatune LW, Wang P, DiFiglia M, Li X (2014) Glucose transporter 3 is a rab11-dependent trafficking cargo and its transport to the cell surface is reduced in neurons of CAG140 Huntington\u2019s disease mice. Acta Neuropathol Commun 2:179. https:\/\/doi.org\/10.1186\/s40478-014-0178-7","journal-title":"Acta Neuropathol Commun"},{"issue":"5 Pt 1","key":"1869_CR34","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/s1525-0016(03)00063-7","volume":"7","author":"TW Miller","year":"2003","unstructured":"Miller TW, Shirley TL, Wolfgang WJ, Kang X, Messer A (2003) DNA vaccination against mutant huntingtin ameliorates the HDR6\/2 diabetic phenotype. Mol Ther 7(5 Pt 1):572\u2013579. https:\/\/doi.org\/10.1016\/s1525-0016(03)00063-7","journal-title":"Mol Ther"},{"issue":"11","key":"1869_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008025","volume":"4","author":"H Moffitt","year":"2009","unstructured":"Moffitt H, McPhail GD, Woodman B, Hobbs C, Bates GP (2009) Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington\u2019s disease. PLoS ONE 4(11):e8025. https:\/\/doi.org\/10.1371\/journal.pone.0008025","journal-title":"PLoS ONE"},{"issue":"3","key":"1869_CR36","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3233\/JHD-170253","volume":"6","author":"MT Montojo","year":"2017","unstructured":"Montojo MT, Aganzo M, Gonz\u00e1lez N (2017) Huntington\u2019s Disease and Diabetes: Chronological Sequence of its Association. J Huntingtons Dis 6(3):179\u2013188. https:\/\/doi.org\/10.3233\/JHD-170253","journal-title":"J Huntingtons Dis"},{"issue":"7","key":"1869_CR37","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s00726-017-2417-2","volume":"49","author":"V Morea","year":"2017","unstructured":"Morea V, Bidollari E, Colotti G, Fiorillo A, Rosati J, De Filippis L, Squitieri F, Ilari A (2017) Glucose transportation in the brain and its impairment in Huntington disease: one more shade of the energetic metabolism failure? Amino Acids 49(7):1147\u20131157. https:\/\/doi.org\/10.1007\/s00726-017-2417-2","journal-title":"Amino Acids"},{"key":"1869_CR38","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13578-020-00459-3","volume":"10","author":"L Niu","year":"2020","unstructured":"Niu L, Li L, Yang S, Wang W, Ye C, Li H (2020) Disruption of zinc transporter ZnT3 transcriptional activity and synaptic vesicular zinc in the brain of Huntington\u2019s disease transgenic mouse. Cell Biosci 10:106. https:\/\/doi.org\/10.1186\/s13578-020-00459-3","journal-title":"Cell Biosci"},{"key":"1869_CR39","doi-asserted-by":"publisher","unstructured":"Pogoda A, Chmielewska N, Maciejak P, Szyndler J (2020) Transcriptional dysregulation in Huntington's Disease. The role in pathogenesis and potency for pharmacological targeting. Curr Med Chem. https:\/\/doi.org\/10.2174\/0929867327666200705225821","DOI":"10.2174\/0929867327666200705225821"},{"issue":"9","key":"1869_CR40","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/hmg\/ddg109","volume":"12","author":"B Ravikumar","year":"2003","unstructured":"Ravikumar B, Stewart A, Kita H, Kato K, Duden R, Rubinsztein DC (2003) Raised intracellular glucose concentrations reduce aggregation and cell death caused by mutant huntingtin exon 1 by decreasing mTOR phosphorylation and inducing autophagy. Hum Mol Genet 12(9):985\u2013994. https:\/\/doi.org\/10.1093\/hmg\/ddg109","journal-title":"Hum Mol Genet"},{"issue":"8","key":"1869_CR41","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s00109-004-0552-1","volume":"82","author":"M Ristow","year":"2004","unstructured":"Ristow M (2004) Neurodegenerative disorders associated with diabetes mellitus. J Mol Med (berl) 82(8):510\u2013529. https:\/\/doi.org\/10.1007\/s00109-004-0552-1","journal-title":"J Mol Med (berl)"},{"issue":"5","key":"1869_CR42","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/hmg\/8.5.813","volume":"8","author":"K Sathasivam","year":"1999","unstructured":"Sathasivam K, Hobbs C, Turmaine M, Mangiarini L, Mahal A, Bertaux F, Wanker EE, Doherty P, Davies SW, Bates GP (1999) Formation of polyglutamine inclusions in non-CNS tissue. Hum Mol Genet 8(5):813\u2013822. https:\/\/doi.org\/10.1093\/hmg\/8.5.813","journal-title":"Hum Mol Genet"},{"issue":"1","key":"1869_CR43","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s13311-019-00805-5","volume":"17","author":"NH Sayed","year":"2020","unstructured":"Sayed NH, Fathy N, Kortam MA, Rabie MA, Mohamed AF, Kamel AS (2020) Vildagliptin Attenuates Huntington\u2019s Disease through Activation of GLP-1 Receptor\/PI3K\/Akt\/BDNF Pathway in 3-Nitropropionic Acid Rat Model. Neurotherapeutics 17(1):252\u2013268. https:\/\/doi.org\/10.1007\/s13311-019-00805-5","journal-title":"Neurotherapeutics"},{"issue":"4","key":"1869_CR44","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.arr.2008.04.002","volume":"7","author":"O Schmitz","year":"2008","unstructured":"Schmitz O, Rungby J, Edge L, Juhl CB (2008) On high-frequency insulin oscillations. Ageing Res Rev 7(4):301\u2013305. https:\/\/doi.org\/10.1016\/j.arr.2008.04.002","journal-title":"Ageing Res Rev"},{"issue":"4","key":"1869_CR45","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.cmet","volume":"25","author":"J Shirakawa","year":"2017","unstructured":"Shirakawa J, Fernandez M, Takatani T, El Ouaamari A, Jungtrakoon P, Okawa ER, Zhang W, Yi P, Doria A, Kulkarni RN (2017) Insulin Signaling Regulates the FoxM1\/PLK1\/CENP-A Pathway to Promote Adaptive Pancreatic \u03b2 Cell Proliferation. Cell Metab 25(4):868-882.e5. https:\/\/doi.org\/10.1016\/j.cmet","journal-title":"Cell Metab"},{"issue":"1","key":"1869_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1507\/endocrj.EJ19-0335","volume":"67","author":"J Shirakawa","year":"2020","unstructured":"Shirakawa J, Terauchi Y (2020) Newer perspective on the coupling between glucose-mediated signaling and \u03b2-cell functionality. Endocr J 67(1):1\u20138. https:\/\/doi.org\/10.1507\/endocrj.EJ19-0335","journal-title":"Endocr J"},{"issue":"20","key":"1869_CR47","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1093\/hmg\/ddp336","volume":"18","author":"R Smith","year":"2009","unstructured":"Smith R, Bacos K, Fedele V, Soulet D, Walz HA, Oberm\u00fcller S, Lindqvist A, Bj\u00f6rkqvist M, Klein P, Onnerfjord P, Brundin P, Mulder H, Li JY (2009) Mutant huntingtin interacts with {beta}-tubulin and disrupts vesicular transport and insulin secretion. Hum Mol Genet 18(20):3942\u20133954. https:\/\/doi.org\/10.1093\/hmg\/ddp336","journal-title":"Hum Mol Genet"},{"issue":"2","key":"1869_CR48","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1172\/JCI12029","volume":"108","author":"MK Thomas","year":"2001","unstructured":"Thomas MK, Devon ON, Lee JH, Peter A, Schlosser DA, Tenser MS, Habener JF (2001) Development of diabetes mellitus in aging transgenic mice following suppression of pancreatic homeoprotein IDX-1. J Clin Invest 108(2):319\u2013329. https:\/\/doi.org\/10.1172\/JCI12029","journal-title":"J Clin Invest"},{"issue":"5","key":"1869_CR49","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/ng1787","volume":"38","author":"K Ueki","year":"2006","unstructured":"Ueki K, Okada T, Hu J, Liew CW, Assmann A, Dahlgren GM, Peters JL, Shackman JG, Zhang M, Artner I, Satin LS, Stein R, Holzenberger M, Kennedy RT, Kahn CR, Kulkarni RN (2006) Total insulin and IGF-I resistance in pancreatic beta cells causes overt diabetes. Nat Genet 38(5):583\u2013588. https:\/\/doi.org\/10.1038\/ng1787","journal-title":"Nat Genet"},{"issue":"8","key":"1869_CR50","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S1474-4422(09)70178-4","volume":"8","author":"JM van der Burg","year":"2009","unstructured":"van der Burg JM, Bjorkqvist M, Brundin P (2009) Beyond the brain: widespread pathology in Huntington\u2019s disease. Lancet Neurol 8(8):765\u2013774. https:\/\/doi.org\/10.1016\/S1474-4422(09)70178-4","journal-title":"Lancet Neurol"},{"key":"1869_CR51","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO (2007) Huntington\u2019s disease. Lancet 369:218\u2013228. https:\/\/doi.org\/10.1016\/S0140-6736(07)60111-1","journal-title":"Lancet"},{"issue":"1","key":"1869_CR52","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s40478-020-00964-z","volume":"8","author":"JA White 2nd","year":"2020","unstructured":"White JA 2nd, Krzystek TJ, Hoffmar-Glennon H, Thant C, Zimmerman K, Iacobucci G, Vail J, Thurston L, Rahman S, Gunawardena S (2020) Excess Rab4 rescues synaptic and behavioral dysfunction caused by defective HTT-Rab4 axonal transport in Huntington\u2019s disease. Acta Neuropathol Commun 8(1):97. https:\/\/doi.org\/10.1186\/s40478-020-00964-z","journal-title":"Acta Neuropathol Commun"},{"issue":"51","key":"1869_CR53","doi-asserted-by":"publisher","first-page":"49676","DOI":"10.1074\/jbc.M208756200","volume":"277","author":"CE Wrede","year":"2002","unstructured":"Wrede CE, Dickson LM, Lingohr MK, Briaud I, Rhodes CJ (2002) Protein kinase B\/Akt prevents fatty acid-induced apoptosis in pancreatic beta-cells (INS-1). J Biol Chem 277(51):49676\u201349684. https:\/\/doi.org\/10.1074\/jbc.M208756200","journal-title":"J Biol Chem"},{"issue":"8","key":"1869_CR54","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1271\/bbb.90147","volume":"73","author":"CF Ye","year":"2009","unstructured":"Ye CF, Li H (2009) HSP40 ameliorates impairment of insulin secretion by inhibiting huntingtin aggregation in a HD pancreatic beta cell model. Biosci Biotechnol Biochem 73(8):1787\u20131792. https:\/\/doi.org\/10.1271\/bbb.90147","journal-title":"Biosci Biotechnol Biochem"},{"issue":"49","key":"1869_CR55","doi-asserted-by":"publisher","first-page":"24840","DOI":"10.1073\/pnas.1908113116","volume":"116","author":"F Yildirim","year":"2019","unstructured":"Yildirim F, Ng CW, Kappes V, Ehrenberger T, Rigby SK, Stivanello V, Gipson TA, Soltis AR, Vanhoutte P, Caboche J, Housman DE, Fraenkel E (2019) Early epigenomic and transcriptional changes reveal Elk-1 transcription factor as a therapeutic target in Huntington\u2019s disease. Proc Natl Acad Sci U S A 116(49):24840\u201324851. https:\/\/doi.org\/10.1073\/pnas.1908113116","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1869_CR56","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1385\/JMN:15:1:31","volume":"15","author":"Z Yu","year":"2000","unstructured":"Yu Z, Zhou D, Cheng G, Mattson MP (2000) Neuroprotective role for the p50 subunit of NF-kappaB in an experimental model of Huntington\u2019s disease. J Mol Neurosci 15(1):31\u201344. https:\/\/doi.org\/10.1385\/JMN:15:1:31","journal-title":"J Mol Neurosci"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-021-01869-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-021-01869-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-021-01869-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T03:19:24Z","timestamp":1637291964000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12031-021-01869-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,31]]},"references-count":56,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1869"],"URL":"https:\/\/doi.org\/10.1007\/s12031-021-01869-9","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,31]]},"assertion":[{"value":"1 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with animals or human participants performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}